WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-01·Latest →

Gilead Sciences (GILD) Stock Analysis

OW

GILD Equity Research — OVERWEIGHT — July 2026

← DHRISRG →

Rating date

Jul 1, 2026

40 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

48p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · GILD

Here is the analysis for GILD.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • GILD's year-long rally has broken down — the June 2026 correction pushed price below both the 50-day and 200-day SMAs for the first time in the data window.
  • Momentum is improving from deeply oversold levels, but has not yet turned positive. The RSI recovery from 29 to 47 and the narrowing MACD are encouraging but inconclusive.
  • The $128–$129 zone is the immediate battleground. A reclaim of this area (both SMAs) would shift the bias back toward bullish; failure to do so keeps the near-term path of least resistance lower.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

GILD Research Note

Full desk note for Jul 1, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

22 min read

WebserviceX · Agentic Research Desk

GILD Equity Research Note

Published Jul 1, 2026 · Desk view OVERWEIGHT · Generated 2026-07-02T20:30:08Z · Maintained by Walter Vijayakumar · Methodology · Track record

GILD Stock Rating Summary

GILD bias

OVERWEIGHT

Horizon

Short to medium term

GILD key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

GILD catalyst watch

GILD's year-long rally has broken down — the June 2026 correction pushed price below both the 50-day and 200-day SMAs for the first time in the data window.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 48p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-02T20:45:19.597003+00:00.

5D move

—

2026-07-01 → awaiting

Outcome

Awaiting market data

5D trend

+0.65%

Vol (20D ann.)

+25.85%

vs SPY: -1.06%

Close 125.97 → — (USD, vendor closes)

Batch scorecard · 2026-07-01 · GILD

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 9a70d85c…

No QC issues recorded.